EMCDDA activities related to drug

related infectious diseases

Roland Simon, Klaudia Palczak, Dagmar Hedrich

TT/CSF, Luxembourg, 18.-20. April 2016

2

emcdda.europa.eu

New data and results from

o 1/16: Naloxone report

o 4/16: Drug related acute intoxications/emergencies

o 4/16: EU Drug Markets report

Further activities in 2016

o 5/16: EDR

o 6/16: Hepatitis C treatment for PWID

o EDRR prepared

o Expert meetings

o Drug related deaths projects

o Network development

o Cooperation

Overview

3

emcdda.europa.eu

Some data and results

4

emcdda.europa.eu

Opioids: Opium production increased

5

emcdda.europa.eu

Opioids: EU market situation

6

emcdda.europa.eu

Preventing infections, overdoses and deaths

6

Opioid substitution treatment — evidence

Naloxone schemes — increase

Drug consumption rooms — debated

7

emcdda.europa.eu

Over 50 % of problem opioid users receive treatment

737 000 receive opioid

substitution treatment,

but numbers decreasing

Percentage of problem opioid users

receiving substitution treatment (estimate)

Trends in number of clients in OST

8

emcdda.europa.eu

Trends in treatment of opioid problems

New heroin clients

more than halved from

2007 to 2013

9

emcdda.europa.eu

HIV diagnoses after harm reduction interventions

Source: ECDC/EMCDDA

10

emcdda.europa.eu

HIV diagnoses after harm reduction interventions

1 458 new cases

among injecting

drug users in 2013

11

emcdda.europa.eu

Hepatitis C: Testing and treatment needed

HCV antibody levels

among drug injectors

vary between 14 %

and 84 %

New diagnostic tools

and medications

available

High treatment costs

are dropping fast

1

1

HCV antibody prevalence among injecting drug users

12

emcdda.europa.eu

Drug and deaths

Drug-induced mortality rates among adults

Highest overdose mortality

rates in Northern countries

Over 6 100 deaths in 2013

13

emcdda.europa.eu

Further activities in 2016

14

emcdda.europa.eu

Major EMCDDA activities in 2016

European Reports

• EDR package 2016: Lisbon launch May 31st

• Drugs Response Report 2017: Preparation

EMCDDA publications

• Insight publication on HCV treatment among PWID

• Rapid communication Infectious diseases and drug harms

Key EMCDDA experts meetings

• June – TDI/DRID Expert meeting

• September – DRD Expert meeting

15

emcdda.europa.eu

Major EMCDDA activities in 2016

Support and collaboration

• with EU-funded projects and Joint Action

• with ECDC, WHO, UNAIDS

• Regional HIV risk assessment, as requested

Topics of special concern

• Chemsex

• Misuse/diversion of substitution substances

• DRD amongst PWID

16

emcdda.europa.eu

Overdose deaths

Over 6 100 deaths in 2013

Recent increases a concern Research on reasons for

increase in Sweden,

Scotland, Denmark end

other Member States:

• Age

• Purity

• Shortage

• Misuse

17

emcdda.europa.eu

Best Practice Portal: Regular update

18

emcdda.europa.eu

Major EMCDDA activities in 2016

Working with out networks

• DRID network – this year in exchange with TDI network

• Special networks for specific discussions and dissemination:

• EURO-DEN

• Trendspotter

Putting things in perspective

• Illicit substances, NPS and legal substances

• Different viewpoints: therapists, social workers, criminal investigators, toxicologists

19

emcdda.europa.eu

Thank you!

www.emcdda.europa.eu